Corporate ActionMay 8, 2026, 04:27 PM
Artiva Biotherapeutics to Raise $300M in Stock & Warrant Offering
AI Summary
Artiva Biotherapeutics, Inc. entered into an underwriting agreement to issue and sell 23,871,526 shares of common stock at $11.52 per share and pre-funded warrants to purchase 2,170,138 shares at $11.5199 per warrant. The offering is expected to generate approximately $300.0 million in gross proceeds for the company. The closing of the offering is anticipated on May 11, 2026, subject to customary conditions.
Key Highlights
- Artiva Biotherapeutics to issue 23,871,526 shares of common stock.
- Common stock priced at $11.52 per share.
- Company to sell pre-funded warrants for 2,170,138 shares.
- Pre-funded warrants priced at $11.5199 each.
- Gross proceeds from the offering expected to be approximately $300.0 million.
- Offering expected to close on May 11, 2026.
Price Impact
More from ARTV